De Motu Cordis

    OverviewSuggest Edit

    De Motu Cordis (DMC) is a pharmaceutical and medical device company. It is engaged in the commercial development of drug-device combination products for drug delivery in emergency indications including cardiac arrest and anaphylaxis.
    TypePrivate
    Founded2015
    Websitedemotucordis.co

    Latest Updates

    Employees (est.) (Nov 2021)8(+15%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at De Motu Cordis

    John F Fraser

    John F Fraser

    Founder and Chairman
    Sonia Barber

    Sonia Barber

    Non-Executive Director
    Show more

    De Motu Cordis Financials and Metrics

    Summary Metrics

    Founding Date

    2015

    De Motu Cordis Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    97/100

    SecurityScorecard logo

    De Motu Cordis Online and Social Media Presence

    Embed Graph

    De Motu Cordis Frequently Asked Questions

    • When was De Motu Cordis founded?

      De Motu Cordis was founded in 2015.

    • Who are De Motu Cordis key executives?

      De Motu Cordis's key executives are John F Fraser and Sonia Barber.

    • How many employees does De Motu Cordis have?

      De Motu Cordis has 8 employees.

    • Who are De Motu Cordis competitors?

      Competitors of De Motu Cordis include iVeena, PhaseBio Pharmaceuticals and JETEMA.